Literature DB >> 25932252

Mean platelet volume levels in the presence of angiographically documented peripheral artery disease.

Ozlem Arican Ozluk1, Ibrahim Ber2, Tezcan Peker1, Mustafa Yilmaz1, Erhan Tenekecioglu1, Kemal Karaagac1, Fahriye Vatansever1.   

Abstract

AIM: Increased mean platelet volume (MPV) have been shown to be associated with peripheral artery disease (PAD). However in these studies, noninvasive methods for the diagnosis of PAD was used. In the literature, there is no studies examining the values of MPV in the angiographically documented PAD. We aimed to evaluate the relationship between angiographically documented PAD and MPV levels in the peripheral blood samples.
METHODS: In this study, retrospective analysis of 1386 patients was performed who underwent peripheral angiography at the cardiology service of the our hospital, between 2006 and 2012 for a suspected diagnosis of lower extremity peripheral arterial disease. Patients with a stenosis percent of 50% or above in the peripheral angiography were considered as having peripheral arterial disease. MPV values are affected by many factor. Only 84 patients who complied with the inclusion criteria were detected. The study patients were divided into 2 groups according to the results of peripheral angiography. 56 patients diagnosed with PAD based on the specified criteria were grouped into Group I (mean age 59 ± 10 years) while 28 patients without peripheral arterial disease were grouped into Group II (mean age 60 ± 11 years). Blood tests and angiographic images were analyzed from patients' data.
RESULTS: Both groups were similar in terms of basic parameters of anemia including hemoglobin, hematocrit and red cell distribution width levels. There were no significant differences between MPV levels in both groups (8.08 ± 0.91 vs 8.28 ± 1.16, P > 0.05). Mean corpuscular volume and mean corpuscular hemoglobin levels, on the other hand, were significantly higher in Group I (P < 0.05).
CONCLUSIONS: In our study, we did not found any significant changes in the MPV levels of angiographically documented PAD diseases. The use of MPV level as a risk factor for peripheral arterial disease is impractical due to the fact that MPV is affected by a lot of factors and there are several technical factors. Because of this, in the real life, we are not recommend to use MPV values as an indicator for peripheral artery disease.

Entities:  

Keywords:  Peripheral arterial disease; mean platelet volume; peripheral angiography

Year:  2015        PMID: 25932252      PMCID: PMC4402899     

Source DB:  PubMed          Journal:  Int J Clin Exp Med        ISSN: 1940-5901


  33 in total

1.  Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report.

Authors: 
Journal:  Circulation       Date:  2002-12-17       Impact factor: 29.690

Review 2.  Platelets in atherothrombosis.

Authors:  Zaverio M Ruggeri
Journal:  Nat Med       Date:  2002-11       Impact factor: 53.440

3.  Erythrocyte mean corpuscular volume associated with severity of peripheral arterial disease: an angiographic evaluation.

Authors:  Meinhard Haltmayer; Thomas Mueller; Christian Luft; Werner Poelz; Dieter Haidinger
Journal:  Ann Vasc Surg       Date:  2002-06-27       Impact factor: 1.466

4.  Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II).

Authors:  L Norgren; W R Hiatt; J A Dormandy; M R Nehler; K A Harris; F G R Fowkes
Journal:  J Vasc Surg       Date:  2007-01       Impact factor: 4.268

5.  ESC Guidelines on the diagnosis and treatment of peripheral artery diseases: Document covering atherosclerotic disease of extracranial carotid and vertebral, mesenteric, renal, upper and lower extremity arteries: the Task Force on the Diagnosis and Treatment of Peripheral Artery Diseases of the European Society of Cardiology (ESC).

Authors:  Michal Tendera; Victor Aboyans; Marie-Louise Bartelink; Iris Baumgartner; Denis Clément; Jean-Philippe Collet; Alberto Cremonesi; Marco De Carlo; Raimund Erbel; F Gerry R Fowkes; Magda Heras; Serge Kownator; Erich Minar; Jan Ostergren; Don Poldermans; Vincent Riambau; Marco Roffi; Joachim Röther; Horst Sievert; Marc van Sambeek; Thomas Zeller
Journal:  Eur Heart J       Date:  2011-08-26       Impact factor: 29.983

6.  Coronary heart disease is associated with mean platelet volume in type 2 diabetic patients.

Authors:  Yusuf Tavil; Nihat Sen; Hüseyin Yazici; Murat Turfan; Fatma Hizal; Atiye Cengel; Adnan Abaci
Journal:  Platelets       Date:  2010       Impact factor: 3.862

7.  Platelet size as a determinant of platelet function.

Authors:  C B Thompson; J A Jakubowski; P G Quinn; D Deykin; C R Valeri
Journal:  J Lab Clin Med       Date:  1983-02

8.  Incidence of and risk factors for asymptomatic peripheral arterial occlusive disease: a longitudinal study.

Authors:  J D Hooi; A D Kester; H E Stoffers; M M Overdijk; J W van Ree; J A Knottnerus
Journal:  Am J Epidemiol       Date:  2001-04-01       Impact factor: 4.897

9.  Size dependent platelet subpopulations: relationship of platelet volume to ultrastructure, enzymatic activity, and function.

Authors:  C B Thompson; K A Eaton; S M Princiotta; C A Rushin; C R Valeri
Journal:  Br J Haematol       Date:  1982-03       Impact factor: 6.998

10.  2011 ACCF/AHA Focused Update of the Guideline for the Management of patients with peripheral artery disease (Updating the 2005 Guideline): a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines.

Authors: 
Journal:  Circulation       Date:  2011-09-29       Impact factor: 29.690

View more
  2 in total

1.  Relationship between Mean Platelet Volume and Critical Limb Ischemia in Diabetes Mellitus Patients.

Authors:  Muhammad Berian Rachmanadi; Muhamad Taufik Ismail; Vita Yanti Anggraeni
Journal:  Int J Angiol       Date:  2021-04-20

2.  Thrombus aspiration during primary percutaneous coronary intervention associated with reduced platelet activation.

Authors:  Muslum Sahin; Goksel Acar; Mehmet E Kalkan; Rezzan D Acar; Alev Kilicgedik; Burak Teymen; Ugur Arslantas; Cevat Kirma
Journal:  Saudi Med J       Date:  2015-08       Impact factor: 1.484

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.